Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders

Keyphrases

• Psychiatric Disorders 100%
• Neurological Disorders 100%
• Potential Therapeutics 100%
• Dopamine Receptor 100%
• Neural Pathways 100%
• Subtype Selectivity 100%
• Selective Agents 100%
• Mesocortical 50%
• Nucleus Accumbens 50%
• Pathophysiology 50%
• Cell Membrane 50%
• Neurotransmitters 50%
• Movement Disorders 50%
• Hyperactivity Disorder 50%
• Central Nervous System 50%
• Dopamine 50%
• G Protein 50%
• Effector Molecules 50%
• Parkinson's Disease 50%
• Motivation 50%
• Dopaminergic System 50%
• Ion Channels 50%
• Cognitive Function 50%
• Large Proteins 50%
• Cerebral Cortex 50%
• Neuronal Function 50%
• Ventral Tegmental Area 50%
• Dorsolateral Prefrontal Cortex (DLPFC) 50%
• Midbrain 50%
• Limbic System 50%
• Emotional Response 50%
• Mesolimbic System 50%
• Cytoplasmic Effectors 50%
• Neurobehavioral Disorders 50%
• Hydrophobic Segment 50%
• Ventral Tegmentum 50%

Neuroscience

• Dopamine Receptor 100%
• Receptor Subtype 100%
• Neurological Disorder 100%
• Neural Pathway 100%
• Nucleus Accumbens 50%
• Dopaminergic 50%
• Neurotransmitter 50%
• Cell Membrane 50%
• Ion Channel 50%
• Hyperactivity 50%
• Central Nervous System 50%
• G Protein 50%
• Cognitive Function 50%
• Parkinson's Disease 50%
• Cerebral Cortex 50%
• Ventral Tegmental Area 50%
• Dorsolateral Prefrontal Cortex 50%
• Limbic System 50%
• Midbrain Tegmentum 50%